5-(2-Chloro-5-nitro-phenyl)-furan-2-carbaldehyde, 100mg

(S)-2-(6-Benzhydrylpyridin-2-yl)-4-cyclohexyl-4,5-dihydrooxazole, 97%, 1g

1,3-Dimesityl-4,5-dihydro-1H-imidazol-3-ium tetrafluoroborate, 95%, 1g

4-Amino-2-hydroxy-3-methoxybenzoic acid, 97%, 250mg

5'-(4-Carboxyphenyl)-[1,1':3',1''-terphenyl]-3,4'',5-tricarboxylic acid, 97%, 100mg

(S)-Methyl 2-amino-3-(4-bromophenyl)propanoate hydrochloride, 95.0%, 5g

Poly(vinylidene fluoride) (powder), 100g

Sodium (S)-2-(6-hydroxybenzo[d]thiazol-2-yl)-4,5-dihydrothiazole-4-carboxylate, 95.0%, 1mg

5-Bromo-3-iodo-2-methoxypyridine, 95.0%, 5g

8-Fluoroquinoline-6-carbaldehyde, 98%, 500mg

DL-SULFORAPHANE, 95.0%, 1g

2-Bromo-5-fluoro-4-iodopyridine, 95.0%, 25g

Ácido L(+)-tartárico, mínimo 99,7 %, para bioquímica, 500 g, envase de plástico.